Motilal Oswal Quant Fund - Direct - Growth is an equity scheme managed by Motilal Oswal Mutual Fund. The total expense ratio is 0.83% on assets of ₹247Cr. The fund is currently managed by Mr. Ankit Agarwal, appointed within the last year.
Lower is better.
This scheme classifies as Large-Blend on the 3x3 equity style box, with 89% of its portfolio classified as of 2026-05-29.
| Holding | Sector |
|---|
| Window | Min | P25 | Median |
|---|
Point-in-time CAGRs cherry-pick a single start date. The chart below shows the distribution of every possible rolling start over the fund's history, so you see the range of investor outcomes — not just one date's number.
Backtested SIP outcomes across both rolling-window scenarios and named historical stress events (COVID, Election uncertainty, Russia/Ukraine, etc.), plus per-manager alpha during their tenure on this scheme.
Same fund, monthly SIPs over rolling 1/3/5-year windows.
Mutual fund investments are subject to market risks. Read all scheme-related documents carefully. Past performance is not indicative of future results. MintByte is an AMFI-registered Mutual Fund Distributor (ARN-314872) and APMI member (APRN-01658). MintByte does not issue buy/sell recommendations on specific securities — the site is an educational data and analytics platform. Star ratings on this page reflect a 3-year category-quartile position computed in-house and are educational only.
Mutual fund schemes are subject to market risk. Read all scheme-related documents carefully before investing. Past performance is not indicative of future results. MintByte is an AMFI-registered mutual fund distributor (ARN-314872). MintByte does not issue buy/sell recommendations on specific securities — the site is an educational data and analytics platform. Not investment advice. Methodology · How we earn.
In-house derivations using 3-year daily NAV vs benchmark. See methodology.
| Weight |
|---|
| PREMIER ENERGIES LIMITED | Technology | 5.72% |
| GLENMARK PHARMACEUTICALS LIMITED | Healthcare | 5.11% |
| TORRENT POWER LIMITED | Utilities | 4.96% |
| WAAREE ENERGIES LIMITED | Technology | 4.68% |
| DIXON TECHNOLOGIES (INDIA) LIMITED | Technology | 4.52% |
| KALYAN JEWELLERS INDIA LIMITED | Consumer Cyclical | 4.46% |
| LUPIN LIMITED | Healthcare | 4.43% |
| HINDUSTAN ZINC LIMITED | Basic Materials | 4.42% |
| MUTHOOT FINANCE LIMITED | Financial Services | 4.32% |
| HERO MOTOCORP LIMITED | Consumer Cyclical | 4.00% |
| Canara Bank | Financial Services | 3.72% |
| HINDUSTAN PETROLEUM CORPORATION LIMITED | Energy | 3.69% |
| BHARAT PETROLEUM CORPORATION LTD. | Energy | 3.52% |
| INDIAN OIL CORPORATION LIMITED | Energy | 3.50% |
| ASHOK LEYLAND LIMITED | Industrials | 3.33% |
| SUZLON ENERGY LIMITED | Industrials | 3.04% |
| INDIAN RENEWABLE ENERGY DEVELOPMENT AGENCY LIMITED | Financial Services | 2.58% |
| BSE LIMITED | Financial Services | 2.54% |
| LIFE INSURANCE CORPORATION OF INDIA | Financial Services | 2.25% |
| PUNJAB NATIONAL BANK | Financial Services | 2.04% |
| POLYCAB INDIA LIMITED | Industrials | 2.03% |
| Hindustan Aeronautics Ltd | Industrials | 2.02% |
| BAJAJ AUTO LIMITED | Consumer Cyclical | 1.91% |
| Persistent Systems Ltd | Technology | 1.77% |
| VEDANTA LIMITED | Basic Materials | 1.74% |
| Sector | Holdings | Weight |
|---|---|---|
| Capital Goods | — | 22.42% |
| Financial Services | 6 | 19.88% |
| Oil, Gas & Consumable Fuels | — | 10.71% |
| Healthcare | 2 | 9.54% |
| Consumer Durables | — | 8.98% |
| Metals & Mining | — | 7.72% |
| Automobile and Auto Components | — | 7.58% |
| Power | — | 6.52% |
| Information Technology | — | 5.16% |
Active bets vs the average Equity fund. Biggest deviations shown first.
Accent bar = fund's actual sector weight. Vertical black tick = category average for the same sector. Green overlay = overweight, dashed red = underweight. The biggest active bets show first.
| P75 |
|---|
| Max |
|---|
| Positive % |
|---|
| 1Y | -13.92% | -8.56% | -3.20% | 2.56% | 18.41% | 37.0% |
Top-10 weight 46.6% means concentration is in line with most actively-managed Indian equity funds. Effective-N is the inverse Herfindahl index — a measure of "how many positions effectively drive the fund" after weighting. Category: Equity.
Compounding maths on a notional ₹10 lakh lumpsum at 12% gross annual return. Green bar is what you'd have without the fee; red overlay is the fee drag. Fee is constant in this scenario — actual outcomes depend on real returns and any future TER changes.
What an investor SIPping into this fund actually got during named market shocks.
Each row is a back-tested SIP — monthly contribution over the regime's duration, no fees adjustment beyond NAV-baked TER. XIRR is the annualised IRR of those cashflows; Abs return is the absolute cash-on-cash; Max DD is the deepest drawdown experienced mid-investment. Past performance is not indicative of future results.
Alpha is the annualised excess return vs benchmark over the manager's tenure on this scheme. Beat-benchmark = total return beat the index over the same window.
Does the fund get worse as it gets bigger? Each dot is one historical manager-tenure: AUM at tenure-end vs alpha delivered during that tenure.
Correlation is too weak to confirm or rule out capacity-driven alpha decay. Re-evaluate as more manager-tenure data accumulates.
Each dot is one manager-tenure: X = AUM at tenure end, Y = alpha during that tenure. Connecting line in chronological order. Pearson r measures the linear relationship between AUM and alpha across the historical record. n = 3 data points.